Inventor · disambiguated record
Rajender Kamboj
Also filed as: KAMBOJ RAJENDER · KAMBOJ RAJENDER K · KAMBOJ RAJENDER KUMAR
113 granted patents·35 pending applications·693 citations·filing 1992–2022
99Inventor score
Top patents by PatentIndex Score
148 records- 0195US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0295US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0395US7511018B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2005·Granted Mar 31, 2009·27 cites·18 claims
- 0494US8030488B2Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Oct 4, 2011·34 cites·28 claims
- 0593US7767677B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·34 cites·10 claims
- 0692US7799798B2Spiroheterocyclic compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Sep 21, 2010·26 cites·9 claims
- 0792US7592343B2Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Sep 22, 2009·22 cites·6 claims
- 0892US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0991US11952380B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2022·Granted Apr 9, 2024·3 cites·20 claims
- 1091US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 1191US7547698B2Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)XENON PHARMACEUTICALS INC·Filed 2005·Granted Jun 16, 2009·18 cites·9 claims
- 1288US9073943B2Antiviral compounds with a dibenzooxaheterocycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·8 cites·22 claims
- 1388US7777036B2Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·13 cites·9 claims
- 1486US8541457B2Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitorsFU JIANMIN·Filed 2006·Granted Sep 24, 2013·16 cites·4 claims
- 1586US8258160B2SCD1 inhibitors triazole and tetrazole compoundsDALES NATALIE·Filed 2007·Granted Sep 4, 2012·11 cites·17 claims
- 1686US7893206B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2009·Granted Feb 22, 2011·5 cites·17 claims
- 1786US7514436B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Apr 7, 2009·22 cites·30 claims
- 1886US7456180B2Piperazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·24 cites·25 claims
- 1985US9399638B2Substituted pyridine compounds as CRAC modulatorsLUPIN LTD·Filed 2013·Granted Jul 26, 2016·11 cites·11 claims
- 2085US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 2184US8338450B2Compounds as dipeptidyl peptidase IV (DPP IV) inhibitorsARORA SUDERSHAN·Filed 2008·Granted Dec 25, 2012·28 cites·23 claims
- 2283US9073942B2Antiviral compounds with a heterotricycle moietyLUPIN LTD·Filed 2013·Granted Jul 7, 2015·9 cites·23 claims
- 2383US8063084B2Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levelsDALES NATALIE·Filed 2007·Granted Nov 22, 2011·6 cites·14 claims
- 2482US8507435B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofGOLDBERG YIGAL·Filed 2012·Granted Aug 13, 2013·5 cites·12 claims
- 2581US9598391B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2015·Granted Mar 21, 2017·4 cites·14 claims
- 2681US8071603B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsKAMBOJ RAJENDER·Filed 2005·Granted Dec 6, 2011·10 cites·5 claims
- 2779US11459330B2Substituted bicyclic heterocyclic compounds as PRMT5 inhibitorsLUPIN LTD·Filed 2018·Granted Oct 4, 2022·3 cites·17 claims
- 2879US8946432B2Biaryl derivatives as nAChR modulatorsSINHA NEELIMA·Filed 2012·Granted Feb 3, 2015·4 cites·10 claims
- 2978US12391695B2PRMT5 inhibitorsLUPIN LTD·Filed 2020·Granted Aug 19, 2025·1 cites·11 claims
- 3078US9987249B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN ATLANTIS HOLDINGS SA·Filed 2017·Granted Jun 5, 2018·3 cites·15 claims
- 3178US9163001B2Substituted chroman compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Oct 20, 2015·4 cites·29 claims
- 3278US8501746B2Organic compoundsDALES NATALIE·Filed 2007·Granted Aug 6, 2013·3 cites·16 claims
- 3378US8148378B2Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammalGSCHWEND HEINZ W·Filed 2009·Granted Apr 3, 2012·5 cites·29 claims
- 3478US8026360B2Substituted pyridazines as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·3 cites·5 claims
- 3577US9555035B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2016·Granted Jan 31, 2017·2 cites·42 claims
- 3677US9393247B2Heteroaryl derivatives as alpha7 nAChR modulatorsLUPIN LTD·Filed 2015·Granted Jul 19, 2016·3 cites·22 claims
- 3775US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 3875US5830712ASelective template deletion methodALLELIX BIOPHARMA·Filed 1996·Granted Nov 3, 1998·67 cites·3 claims
- 3974US12435066B2Substituted tricyclic compoundsLUPIN LTD·Filed 2020·Granted Oct 7, 2025·1 cites·27 claims
- 4073US9428499B2Heterocyclyl compounds as MEK inhibitorsLUPIN LTD·Filed 2013·Granted Aug 30, 2016·2 cites·28 claims
- 4173US9382216B2Substituted morpholines as modulators for the calcium sensing receptorSHUKLA MANOJKUMAR RAMPRASAD·Filed 2012·Granted Jul 5, 2016·2 cites·11 claims
- 4273US8252578B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofGOLDBERG YIGAL P·Filed 2011·Granted Aug 28, 2012·1 cites·16 claims
- 4372US9227919B2Arylalkylamine compounds as calcium sensing receptor modulatorsLUPIN LTD·Filed 2013·Granted Jan 5, 2016·2 cites·16 claims
- 4472US9072731B2Heteroaryl derivatives as alpha7 nAChR modulatorsSINHA NEELIMA·Filed 2012·Granted Jul 7, 2015·3 cites·39 claims
- 4572US7919496B2Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymesXENON PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·1 cites·10 claims
- 4671US9359367B2Tetrahydroquinazolinone derivatives as PARP inhibitorsLUPIN LTD·Filed 2013·Granted Jun 7, 2016·3 cites·19 claims
- 4771US7829712B2Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturaseXENON PHARMACEUTICALS INC·Filed 2005·Granted Nov 9, 2010·1 cites·16 claims
- 4869US9737534B2Oxazoline and isoxazoline derivatives as CRAC modulatorsLUPIN LTD·Filed 2015·Granted Aug 22, 2017·1 cites·8 claims
- 4967US7763618B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Jul 27, 2010·2 cites·43 claims
- 5065US9493396B2Substituted naphthalene compounds as calcium sensing receptor modulatorsLUPIN ATLANTIS HOLDINGS SA·Filed 2014·Granted Nov 15, 2016·1 cites·18 claims
Showing the top 50 of 148 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rajender Kamboj files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →